The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation (original) (raw)

Treatment With Prolonged-Release Oxycodone/Naloxone Improves Pain Relief and Opioid-Induced Constipation Compared With Prolonged-Release Oxycodone in Patients With Chronic Severe Pain and Laxative-Refractory Constipation

David Logé

Clinical Therapeutics, 2015

View PDFchevron_right

Reviews The place of oxycodone/naloxone in chronic pain management

Wojciech Leppert

Współczesna Onkologia, 2013

View PDFchevron_right

Chapter 6 Prolonged release oxycodone and naloxone treatment counteracts opioid induced constipation for patients with severe pain compared to previous analgesic treatment

ISABELLE MANCINI

2019

View PDFchevron_right

Combined oral prolonged-release oxycodone and naloxone in chronic pain management

Antonello Giarratano

Expert Opinion on Investigational Drugs, 2013

View PDFchevron_right

Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction

Wojciech Leppert

Drug Design, Development and Therapy, 2015

View PDFchevron_right

Oral Prolonged-Release Oxycodone/Naloxone for Managing Pain and Opioid-Induced Constipation: A Review of the Evidence

Tony O’Brien, Wojciech Leppert

Pain Practice, 2017

View PDFchevron_right

Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives

karen simpson

Current medical research and opinion, 2014

View PDFchevron_right

A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation

Christian Ruckes

European Journal of Pain, 2009

View PDFchevron_right

Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain

Christian Ruckes

International Journal of Clinical Practice, 2008

View PDFchevron_right

A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain

Sam Ahmedzai

Palliative Medicine, 2012

View PDFchevron_right

Prolonged-release oxycodone/naloxone reduces opioid-induced constipation and improves quality of life in laxative-refractory patients: results of an observational study

Carsten Bantel

Clinical and experimental gastroenterology, 2018

View PDFchevron_right

Prolonged-Release Oxycodone/Naloxone in Nonmalignant Pain: Single-Center Study in Patients with Constipation

Manuela Casali

Advances in Therapy, 2013

View PDFchevron_right

Long‐term efficacy and safety of combined prolonged‐release oxycodone and naloxone in the management of non‐cancer chronic pain

Michael Hopp

… journal of clinical …, 2010

View PDFchevron_right

Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials

Björn Boße

BMC Clinical Pharmacology, 2010

View PDFchevron_right

Oxycodone and Naloxone Combination: A 12-Week Follow-up in 20 Patients Shows Effective Analgesia Without Opioid-Induced Bowel Dysfunction

Shiva Tripathi

Pain and therapy, 2016

View PDFchevron_right

A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160/80 mg daily) vs oxycodone PR

Alex Ellery

European Journal of Pain

View PDFchevron_right

Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain

Sam Ahmedzai

Supportive Care in Cancer, 2014

View PDFchevron_right

Oral Prolonged‐Release Oxycodone‐Naloxone: Analgesic Response, Safety Profile, and Factors Influencing the Response in Patients With Advanced Cancer

Claudio Cartoni

Pain Practice, 2019

View PDFchevron_right

Effectiveness and tolerability of low-dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain: an observational analysis

Francesca Leonardis

Current Medical Research and Opinion, 2013

View PDFchevron_right

Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients

Giovanni Ricevuti

Clinical Interventions in Aging, 2014

View PDFchevron_right

Oral prolonged‐release Oxycodone‐Naloxone: analgesic response, safety profile, and factors influencing the response in advanced cancer patients

Vittorio Iorno

Pain Practice

View PDFchevron_right

Guidelines add latest evidence for managing opioid-induced constipation

Joseph S. Ladd

Pharmacy Today, 2019

View PDFchevron_right

Use of Oxycodone in Pain Management

Saeed Shoar, Mohammad Moradi

Anesthesiology and Pain Medicine, 2012

View PDFchevron_right

Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain

Eric Mortensen

Pain, 2008

View PDFchevron_right

The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety

Jo Ann LeQuang

Drug Design, Development and Therapy, 2020

View PDFchevron_right

Oxycodone: a review of its use in the management of pain

Asbjørn Drewes

Current Medical Research and Opinion, 2008

View PDFchevron_right

Differential Gastrointestinal Effects of Who-Step III Opioids in Low Back Pain Patients with vs. Without Constipation: Post-Hoc Analysis of Data from a 12-Week Prospective, Open-Label Blinded Endpoint Streamlined Study

Peertechz Journals

View PDFchevron_right

Strategies for Combating Opioid-Induced Constipation: Targeted Mechanisms to Maintain Pain Control Without Compromise

Steven Stanos

PM & R : the journal of injury, function, and rehabilitation, 2017

View PDFchevron_right

Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction

Asbjørn Drewes, Christina Brock

Clinical and Experimental Gastroenterology, 2014

View PDFchevron_right